Prevalence of depression in Indian patients with type 2 diabetes mellitus and/or hypertension: DEPTH Study
DOI:
https://doi.org/10.15584/ejcem.2019.4.5Keywords:
comorbidity, diabetes, depression, hypertension, prevalence, type 2 diabetes mellitusAbstract
Introduction. Depression, a common psychiatric mood disorder, is a leading cause of disability and a significant contributor to the overall global burden of disease.
Aim. To determine the prevalence of depression in patients with controlled and uncontrolled type-2 diabetes mellitus (T2DM) and/or hypertension (HTN) in India. The association of depression with socio-demographic profile and clinical risk factors was also assessed.
Material and methods. In this cross-sectional epidemiological study, T2DM and/or HTN patients attending outpatient department at tertiary care hospitals and private clinics across 54 cities in India were enrolled. The primary outcome measure was to determine the prevalence of depression in T2DM, HTN and T2DM + HTN patients. Association of depression with patients’ demography, socio-economic status, anxiety, and clinically diagnosed insomnia were also investigated.
Results. Of 1829 patients, the prevalence of depression in T2DM, HTN and T2DM+HTN cases were found to be 51.03%, 46.94% and 48.64%, respectively. A higher proportion of patients with uncontrolled T2DM and HTN reported depression (T2DM: 77.64% vs. 22.36%; HTN: 72.49% vs. 27.51%). There was a significant association between anxiety and severity of depression across all indications (p<0.0001). Depression was significantly associated with complications in T2DM (p=0.0001) and comorbidities in T2DM + HTN (p=0.0023) cases.
Conclusion. Depression is highly prevalent and has a direct significant association with various socio-demographic variables and anxiety in Indian patients with T2DM and/or HTN.
Downloads
References
World Health Organization [homepage on the internet]: Depression. Fact sheet N 369. Available from: http://www.who.int/news-room/fact-sheets/detail/depression. Accessed Jun 14, 2018.
Grover S, Dutt A, Avasthi A. An overview of Indian research in depression. Indian J Psychiatry. 2010;52(1):178-188.
World Health Organization [homepage on the internet]: Depression in India. Let’s talk. 2017. Available from: http://www.searo.who.int/india/depression_in_india.pdf. Accessed Aug 16, 2018.
Kilzieh N, Rastam S, Maziak W, Ward KD. Comorbidity of depression with chronic diseases: a population-based study in Aleppo, Syria. Int J Psychiatry Med. 2008;38(2):169-184.
Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015;75(6):577-587.
Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P. Prevalence & determinants of depression in type 2 diabetes patients in a tertiary care centre. Indian J Med Res. 2010;(132):195-200.
Das S, Gupta Y, Sehrawat T, Thour A. Depression among patients with diabetes mellitus in North India evaluated using patient health questionnaire-9. Indian J Endocrinol Metab. 2015;19(2):252-255.
Dhavale HS, Panikkar V, Jadhav BS, Ghulghule M, Dagaria A. Depression and diabetes: Impact of antidepressant medications on glycaemic control. J Assoc Physicians India. 2013;61(12):896-899.
Neupane D, Panthi B, McLachlan CS, Mishra SR, Kohrt BA, Kallestrup P. Prevalence of undiagnosed depression among persons with hypertension and associated risk factors: a cross-sectional study in urban Nepal. PloS One. 2015,10(2):e0117329.
Mahmood S, Hassan SZ, Tabraze M, et al. Prevalence and Predictors of Depression Amongst Hypertensive Individuals in Karachi, Pakistan. Cureus. 2017;9(6):e1397.
Hsu YM, Su LT, Chang HM, Sung FC, Lyu SY, Chen PC. Diabetes mellitus and risk of subsequent depression: a longitudinal study. Int J Nurs Stud. 2012;49(4):437-444.
Ciechanowski P. Diapression: an integrated model for understanding the experience of individuals with co-occurring diabetes and depression. Clin Diabetes. 2011;29(2):43-49.
Cheung BM, Li C. Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep. 2012;14(2):160-166.
Mohan V, Seedat YK, Pradeepa R. The rising burden of diabetes and hypertension in southeast asian and african regions: need for effective strategies for prevention and control in primary health care settings. Int J Hypertens. 2013;2013:409083.
Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25(3):464-470.
Zhang Y, Ting RZ, Yang W, et al Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence. J Diabetes. 2015;7(6):800-808.
Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398-2403.
Maguire LK, Hughes CM, McElnay JC. Exploring the impact of depressive symptoms and medication beliefs on medication adherence in hypertension: a primary care study. Patient Educ Couns. 2008;73(2):371-376.
Moise N, Davidson KW, Chaplin W, Shea S, Kronish I. Depression and clinical inertia in patients with uncontrolled hypertension. JAMA Intern Med. 2014;174(5):818-819.
Katon W, Fan MY, Unützer J, Taylor J, Pincus H, Schoenbaum M. Depression and diabetes: a potentially lethal combination. J Gen Intern Med. 2008;23(10):1571-1575.
Wu SF, Huang YC, Liang SY, Wang TJ, Lee MC, Tung HH. Relationships among depression, anxiety, self-care behaviour and diabetes education difficulties in patients with type-2 diabetes: a cross-sectional questionnaire survey. Int J Nurs Stud. 2011;48(11):1376-1383.
Lin EH, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010;33(2):264-269.
Markowitz SM, Gonzalez JS, Wilkinson JL, Safren SA. A review of treating depression in diabetes: emerging findings. Psychosomatics. 2011;52(1):1-18.
Krousel-Wood M, Frohlich ED. Hypertension and depression: co-existing barriers to medication adherence. J Clin Hypertens. 2010;12(7):481-486.
International Diabetes Federation [homepage on the internet]: Global guideline for type 2 diabetes. Available from http://www.diabetesatlas.org/ accessed June 14, 2018.
AlKhathami AD, Alamin MA, Alqahtani AM, Alsaeed WY, AlKhathami MA, Al-Dhafeeri AH. Depression and anxiety among hypertensive and diabetic primary health care patients. Could patients' perception of their diseases control be used as a screening tool? Saudi Med J. 2017;38(6):621-628.
American diabetes association. Standard of medical care-2018. Diabetes care. 2018;41(1):1-159.
Oberoi SS. Updating income ranges for Kuppuswamy's socio-economic status scale for the year 2014. Indian J Public Health. 2015;59(2):156-157.
Khosravi A, Pourheidar B, Roohafza H, et al. Evaluating factors associated with uncontrolled hypertension: Isfahan cohort study, Iran. ARYA Atheroscler. 2014;10(6):311-318.
Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(suppl 3):1-203.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097.
Ali N, Jyotsna VP, Kumar N, Mani K. Prevalence of depression among type 2 diabetes compared to healthy non diabetic controls. J Assoc Physicians India. 2013;61(9):619-621.
Li Z, Li Y, Chen L, Chen P, Hu Y. Prevalence of depression in patients with hypertension: a systematic review and meta-analysis. Medicine. 2015;94(31):e1317.
Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care. 1997;20(4):585-590.
Pouwer F, Kupper N, Adriaanse MC. Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med. 2010;9(45):112-118.
Poongothai S, Anjana RM, Pradeepa R, et al. Association of depression with complications of type 2 diabetes–the Chennai Urban Rural Epidemiology Study (CURES- 102). J Assoc Physicians India. 2011;(59):644-648.
Singh H, Raju MSVK, Dubey V, Kurrey R, Bansal S, Malik M. A study of sociodemographic clinical and glycemic control factors associated with co-morbid depression in type 2 diabetes mellitus. Ind Psychiatry J. 2014;23(2):134-142.
Katon WJ, Von Korff M, Lin EH, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004;61(10):1042-1049.
Egede LE, Ellis C. The effects of depression on metabolic control and quality of life in indigent patients with type 2 diabetes. Diabetes Technol Ther. 2010;12(4):257-262.
Barnes ER, Theeke L, Minchau E, Mallow J, Lucke-Wold N, Wampler J. Relationships between obesity management and depression management in a university-based family medicine center. J Am Assoc Nurse Pract. 2015;27(5):256-261.
Berge LI, Riise T. Comorbidity between Type 2 Diabetes and Depression in the Adult Population: Directions of the Association and Its Possible Pathophysiological Mechanisms. Int J Endocrinol. 2015;2015:164760.
Hamer M, Batty GD, Kivimaki M. Haemoglobin A1c, fasting glucose and future risk of elevated depressive symptoms over 2 years of follow-up in the English Longitudinal Study of Ageing. Psychol Med. 2011;41(9):1889-1896.
Fisher L, Skaff MM, Mullan JT, Arean P, Glasgow R, Masharani U. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med. 2008;25(9):1096-1101.
Ravona-Springer R, Heymann A, Schmeidler J, et al. Hemoglobin A1c variability predicts symptoms of depression in elderly individuals with Type 2 Diabetes. Diabetes Care. 2017;40(9):1187-1193.
Koyanagi A, Garin N, Olaya B, et al. Chronic conditions and sleep problems among adults aged 50 years or over in nine countries: A multi-country study. PLoS One. 2014;9(12):e114742.
Gangwisch JE. Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes Rev. 2009;10(Suppl 2):37-45.
Collins MM, Corcorant P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009;26(2):153-161.
Payne ME, Steck SE, George RR, Steffens DC. Fruit, vegetable, and antioxidant intakes are lower in older adults with depression. J Acad Nutr Diet. 502012;112(12):2022-2027.
Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav. 2009;36(1):127-137.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
